IP Library Granted Patent US 8,116,983
Granted Patent B2
US 8,116,983 · App. 11/476,657 · Granted Feb 14, 2012

Device for quantitative analysis of a drug or metabolite profile

Assignee: Biocrates Life Sciences AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,116,983
App. No.
11/476,657
Granted
Feb 14, 2012
Kind
B2
Abstract

A device, in particular a sample preparation device for the quantitative analysis of a drug and/or metabolite profile in a biological sample, which includes an insert for such a device being impregnated with at least one internal standard, to the internal standard itself, and to a kit comprising the device. Further, the invention also relates to an apparatus containing the device, and to a method for the quantitative analysis of a drug and/or metabolite profile in a biological sample employing the device.

Claims (76)

1. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells,

(B) one or more inserts located in the wells, wherein the insert comprises:

(a) a support comprising a sorbent material for liquids with which the support is impregnated, and

(b) at least one organic internal standard being encapsulated with a covering material protecting the internal standard from degradation and chemical reactivity prior to use, wherein the covering material comprises at least one of a micelle-forming compound, a liposome-forming compound, a polyhydroxy compound, a polymer selected from polyalkylene glycol homopolymers or copolymers or mixtures thereof, and

(C) a retainer holding the insert within the well with a distance between the insert and the the walls and the bottom of the well in order to allow a free circulation of fluids around the insert.

2. The device according to claim 1 , wherein the sorbent material comprises at least one of a cellulose material, glass fibres, glass beads, polyacrylamide gel, porous plastic inert polymer or porous graphite.

3. The device according to claim 1 , wherein the encapsulated standard is microencapsulated.

4. The device according to claim 1 , wherein the polymer is selected from a polyethylene glycol or polypropylene glycol homopolymer or copolymer or a mixture thereof.

5. The device according to claim 4 , wherein the polymer is PEG 1000.

6. The device according to claim 1 , wherein the polyhydroxy compound is selected from sorbitol or glycerol.

7. The device according to claim 1 , wherein the micelle-forming compound is a surfactant.

8. The device according to claim 1 , wherein the liposome forming compound is a phospholipid.

9. The device according to claim 8 , wherein the phosopholipid is a phosphatidyl choline or a phosphatidyl ethanolamine or derivatives thereof.

10. The device according to claim 1 , wherein the one or more wells comprise a filter for separating micron size solids, and an outlet for discharging the filtrate.

11. The device according to claim 10 , wherein the filter is located between the insert and the outlet.

12. The device according to claim 10 , wherein the outlet opens under applied centrifugal force or reduced pressure.

13. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells;

(B) one or more inserts located in the wells, wherein the insert comprises

(a) a support comprising a sorbent material for liquids which support is impregnated with

(b) at least one organic internal standard; and

(C) a retainer holding the insert within the well with a distance between the insert and the walls and the bottom of the well in order to allow a free circulation of fluids around the insert.

14. The device according to claim 13 , wherein the one or more wells comprise a filter for separating micron size solids, and an outlet for discharging the filtrate.

15. The device according to claim 14 , wherein the filter is located between the insert and the outlet.

16. The device according to claim 14 , wherein the outlet ( 5 ) opens under applied centrifugal force or reduced pressure.

17. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells;

(B) one or more inserts located in the wells, wherein the insert comprises:

(a) a support comprising a sorbent material for liquids which support is impregnated with

(b) at least one organic internal standard being encapsulated with a covering material protecting the internal standard from degradation and chemical reactivity prior to use, wherein the covering material comprises at least one of a micelle-forming compound, a liposome-forming compound, a polyhydroxy compound, and a polymer selected from polyalkylene glycol homopolymers or copolymers or mixtures thereof; and

(C) a retainer holding the insert within the well with a distance between the insert and the the walls and the bottom of the well in order to allow a free circulation of fluids around the insert.

18. A kit for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising the device as defined in claim 1 .

19. A kit for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising the device as defined in claim 13 .

20. A kit for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising the device as defined in claim 17 .

21. An apparatus for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(a) a treatment unit for preparing the drugs and/or metabolites to be screened comprising

(a1) an automated liquid handling system, and

(a2) at least one device as defined in claim 1 for derivatization of the drugs and/or metabolites present in the sample and for subsequent extraction of the derivatives;

(b) a mass spectrometer for the quantitative targeted mass spectrometry-based analysis, and

(c) a database for storing results of the analysis.

22. An apparatus for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(a) a treatment unit for preparing the drugs and/or metabolites to be screened comprising

(a1) an automated liquid handling system, and

(a2) at least one device as defined in claim 13 for derivatization of the drugs and/or metabolites present in the sample and for subsequent extraction of the derivatives;

(b) a mass spectrometer for the quantitative targeted mass spectrometry-based analysis, and

(c) a database for storing results of the analysis.

23. An apparatus for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(a) a treatment unit for preparing the drugs and/or metabolites to be screened comprising

(a1) an automated liquid handling system, and

(a2) at least one device as defined in claim 17 for derivatization of the drugs and/or metabolites present in the sample and for subsequent extraction of the derivatives;

(b) a mass spectrometer for the quantitative targeted mass spectrometry-based analysis, and

(c) a database for storing results of the analysis.

24. A device comprising:

a support comprising a sorbent material;

a plurality of mass spectrometry, organic, metabolite standards of known amounts impregnated in the support and dried; and

a well and a retainer, wherein the retainer holds the support within the well.

25. The device of claim 24 , wherein the mass spectrometry, organic, metabolite standards comprise amino acids labelled with stable isotopes.

26. The device of claim 24 , wherein the mass spectrometry, organic, metabolite standards comprise polypeptides labelled with stable isotopes.

27. The device of claim 24 , wherein the mass spectrometry, organic, metabolite standards comprise lipids labelled with stable isotopes.

28. The device of claim 24 , wherein the mass spectrometry, organic, metabolite standards comprise acylcarnitines labelled with stable isotopes.

29. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells, wherein the one or more wells comprise a filter for separating micron size solids, and an outlet for discharging the filtrate; and

(B) one or more inserts located in the wells, wherein the insert comprises:

(a) a support comprising a sorbent material for liquids with which the support is impregnated, and

(b) at least one organic internal standard being encapsulated with a covering material protecting the internal standard from degradation and chemical reactivity prior to use, wherein the covering material comprises at least one of a micelle-forming compound, a liposome-forming compound, a polyhydroxy compound, a polymer selected from polyalkylene glycol homopolymers or copolymers or mixtures thereof, wherein the filter is located between the insert and the outlet.

30. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells, wherein the one or more wells comprise a filter for separating micron size solids, and an outlet for discharging the filtrate and the outlet opens under applied centrifugal force or reduced pressure; and

(B) one or more inserts located in the wells, wherein the insert comprises:

(a) a support comprising a sorbent material for liquids with which the support is impregnated, and

(b) at least one organic internal standard being encapsulated with a covering material protecting the internal standard from degradation and chemical reactivity prior to use, wherein the covering material comprises at least one of a micelle-forming compound, a liposome-forming compound, a polyhydroxy compound, a polymer selected from polyalkylene glycol homopolymers or copolymers or mixtures thereof.

31. A device for the quantitative analysis of a drug and/or a metabolite profile in a biological sample, comprising:

(A) one or more wells,

(B) one or more inserts located in the wells, wherein the insert comprises:

(a) a support comprising a sorbent material for liquids with which the support is impregnated, and

(b) at least one organic internal standard being encapsulated with a covering material protecting the internal standard from degradation and chemical reactivity prior to use, wherein the covering material consists of at least one of a micelle-forming compound, a liposome-forming compound, a polyhydroxy compound, a polymer selected from polyalkylene glycol homopolymers or mixtures thereof.

Assignments (2)
CHANGE OF NAME Recorded Apr 26, 2010
From: BIOCRATES LIFE SCIENCES GMBH
To: BIOCRATES LIFE SCIENCES AG
Reel/Frame 024288/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2007
From: RAMSAY, STEVEN LEWIS; GUGGENBICHLER, WOLFGANG; WEINBERGER, KLAUS MICHAEL; GRABER, ARMIN; STOEGGL, WOLFGANG MARKUS
To: BIOCRATES LIFE SCIENCES GMBH
Reel/Frame 020053/0875 →
Continuity (3)
Provisional Application 60694984 · Jun 30, 2005
Provisional Application 60694983 · Jun 30, 2005
Related Publication 20070003965A1 · Jan 4, 2007